TY  - JOUR

T1  - CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancer.

JO  - MedComm (2020)

PY  - 2021/12/01

AU  - Saleh L

AU  - Wilson C

AU  - Holen I

ED  - 

DO  - DOI: 10.1002/mco2.97

VL  - 2

IS  - 4

SP  - 514

EP  - 530

Y2  - 2024/12/22

ER  -